VASCage is part of the NCD Risk Factor Collaboration (NCD-RisC) who published its latest findings on adiposity and hyptertension in the prestigious journal Lancet. The study, involving an unprecedented 7.5 million participants worldwide, explored the relationship between adiposity and hypertension, offering crucial insights into cardiovascular health.
The research focused on comparing two key measures of adiposity: Body Mass Index (BMI) and Waist-to-Height Ratio (WHtR). BMI, a widely used metric based on weight and height, has long been used to assess body fat. However, abdominal adiposity—excess fat around the abdomen—can be more precisely measured by indices such as WHtR. The study aimed to determine how effectively these metrics can distinguish between individuals with and without hypertension, a major risk factor for stroke and cardiovascular diseases.
The study showed that BMI can distinguish young and middle-aged adults with higher versus lower amounts of abdominal adiposity with moderate-to-high accuracy, and both BMI and WHtR distinguish people with or without hypertension. However, at the same BMI level, people in south Asia, Latin America and the Caribbean, and the region of central Asia, Middle East and north Africa, have higher WHtR than in the other regions.
This publication showcases VASCage GmbH’s expertise in both clinical trials and global epidemiological studies, further highlighting our role in advancing clinical stroke and cardiovascular research.
„General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants“
Zhou, Bin et al. The Lancet, Volume 404, Issue 10455, 851 – 863
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01405-3/fulltext
